Last reviewed · How we verify
Timothy, Phleum pretense — Competitive Intelligence Brief
phase 3
Immunology
Biologic
Live · refreshed every 30 min
Target snapshot
Timothy, Phleum pretense (Timothy, Phleum pretense) — Turku University Hospital. Timothy, Phleum pretense is a plant-based treatment that has been studied for its potential effects on the immune system.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Timothy, Phleum pretense TARGET | Timothy, Phleum pretense | Turku University Hospital | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Timothy, Phleum pretense CI watch — RSS
- Timothy, Phleum pretense CI watch — Atom
- Timothy, Phleum pretense CI watch — JSON
- Timothy, Phleum pretense alone — RSS
Cite this brief
Drug Landscape (2026). Timothy, Phleum pretense — Competitive Intelligence Brief. https://druglandscape.com/ci/timothy-phleum-pretense. Accessed 2026-06-09.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing